HEALTHCARE CONSULTINGHealthcare Consulting

Consulting in the Healthcare Field

(ABOUT)Consulting in the Healthcare Field

With our expertise in using diverse medical information across healthcare and the life sciences, we provide strategic support for business decision-making, evidence generation, and marketing. Additionally, we assist in developing business strategies for new ventures, AI integration, and digital transformation (DX).

For those with the following challenges:

Challenge 1

Want to plan and execute strategies for more effective evidence generation and dissemination at every stage of the product lifecycle!

Challenge 2

Want to appropriately analyze and structure the context of your product, and to plan and execute effective actions!

Challenge 3

Want to identify the right target audience for your product and maximize product value through effective information dissemination!

Consultants who have supported numerous product strategies will assist in solving these challenges!

(BENEFIT)Features of the Healthcare Consulting Business

01

Extensive experience and achievements

Experienced consultants will tailor problem identification and solutions to the client’s department and mission.

02

Goal-oriented problem solving

To address the client's diverse challenges, we build collaborative structures and provide team-based support.

03

Data and evidence orientation

We value objective facts such as data and evidence, and make data-driven proposals.

(CASE STUDY)Examples of projects

Creation of cost-effectiveness evidence in line with drug price revision timing

Creation of cost-effectiveness evidence in line with drug price revision timing

When the market expansion re-calculation was anticipated for the biological drug for chronic disease R, we built a model and conducted a cost-effectiveness analysis. Following the re-calculation, we demonstrated a further improvement in cost-effectiveness and supported the process through to publication in a peer-reviewed journal.

Verification of actual drug usage in clinical practice and reflection in cost-effectiveness models

Verification of actual drug usage in clinical practice and reflection in cost-effectiveness models

Regarding the induction, maintenance, and relapse treatment schedules for hematological malignancy F, we redefined them based on the registration status in the claims database under the advice of clinical specialists, calculated the treatment costs, and then adapted them to a cost-effectiveness model.

PAGE TOP ↑